COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments are working to address the COVID-19 outbreak globally, from supporting the development of vaccines to planning for medicine supply chain challenges.

Currently, about 115 vaccine samples and 155 molecules are in the R&D pipeline. Furthermore, the implementation of lockdown due to the COVID-19 pandemic has delayed the treatment for menstrual cramps; thereby, having a negative impact on the market. This was attributed to the fact that due to the COVID-19 pandemic many hospitals across the globe were restructured to increase hospital capacity for patients diagnosed with COVID-19. This in turn is expected to have a significant impact on the menstrual cramps treatment market. 

Top Impacting Factors

• Lifestyle changes, environmental changes, and food choices have a substantial impact on human bodies. This has increased the prevalence of dysmenorrhea among women, which is a significant driver for the global menstrual cramps treatment market.
• The rise in the prevalence of dysmenorrhea has resulted in an increase in health awareness among women to combat the disorder, which in turn is expected to propel market growth. 
• Consumers' growing awareness of dysmenorrhea treatment and the low cost of over-the-counter pharmaceuticals are two major reasons to propel growth in the menstrual cramps treatment market.
• The upsurge in the use of medications to help with pain during the menstrual cycle, in turn, stimulates the global menstrual cramps treatment market growth.
• Furthermore, the rise in technological advancement in the healthcare industry is expected to drive the growth of the menstrual cramps treatment market during the forecast period.
• However, side effects and problems of long-term care, the high morbidity of dysmenorrhea leading to insufficient therapy, and traditional family values are anticipated to hinder the expansion of the menstrual cramps treatment market.

Market Trends

New Product Launches to Flourish Menstrual Cramps Treatment Market

In July 2020, Teva Pharmaceuticals USA, Inc., which holds Takeda in 
a joint business venture in the Japanese market, announced a new strategy for its local commercial operations. This strategy has enhanced the company's presence in the Japanese market and propels its revenue growth.

In March 2018, GlaxoSmithKline Plc. declared a successful agreement with Novartis to acquire full ownership of the consumer healthcare business. This agreement helped the company to escalate its product portfolio and revenue growth of the company.

In January 2021, Pfizer, Inc. and Myovant Sciences announced a positive phase 3 spirit extension study of once-daily relugolix combination therapy in women with endometriosis. The therapy reported clinically meaningful reductions in dysmenorrhea. 

In September 2019, Bayer announced data demonstrating a single maximum non-prescription dose of Aleve provided more pain relief over 12 hours than acetaminophen for menstrual cramps due to primary dysmenorrhea.

Key Benefits of Report

• This study presents the analytical depiction of the menstrual cramps treatment along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the menstrual cramps treatment market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the menstrual cramps treatment market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
• The report provides a detailed menstrual cramps treatment market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions Answered in Menstrual Cramps Treatment Market Report

• Who are the leading market players active in the menstrual cramps treatment market?
• What current trends will influence the menstrual cramps treatment market in the next few years?
• What are the driving factors, restraints, and opportunities in the menstrual cramps treatment market?
• What future projections would help in taking further strategic steps?
• What is menstrual cramps treatment?
• What is menstrual cramps treatment market prediction for the future?
• Who are the leading global players in the menstrual cramps treatment market?
• What are the current trends and predicted trends?
• What are the key benefits of the menstrual cramps treatment market report?